MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.

A multilaboratory study was performed to establish broth microdilution MIC quality control (QC) guidelines for 10 investigational drugs which previously demonstrated significant activity against Haemophilus influenzae. MIC QC ranges for H. influenzae ATCC 49247 with Haemophilus test medium were dete...

詳細記述

保存先:

書誌詳細
出版年:	J Clin Microbiol
主要な著者:	Bale, M J, Jones, R N, Erwin, M E, Koontz, F P, Gerlach, E H, Murray, P R, Washington, J A
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1992
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC265027/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1310329/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.30.1.225-226.1992
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.

類似資料